This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.
PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic solid cancer and/or disease progression following at least first line systemic therapy and/or relapsed or refractory hematologic cancer.
PATIENT: Have internet access through a computer or a mobile device; the principal investigator (PI) will ensure that those who have access to a computer or mobile device have access to a computer or mobile device with internet access to ensure they can complete study procedures.
PATIENT: The ability to provide informed consent.
PATIENT: Identification of a loved support person if one is available; patients who are unable to identify a support person willing to participate with them will be allowed to continue in the study on their own.
PATIENT: Not fluent in English.
PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of >= 6) to be delivered by trained study research staff during screening.
PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer).
PATIENT: Currently receiving hospice at the time of enrollment.
Parallel
Internet-Based Intervention
Other interventionUse smartphone application
Best Practice
Other interventionEngage in standard care
Telephone-Based Intervention
Other interventionReceive check-in call
Questionnaire Administration
Other interventionAncillary studies
Post-intervention qualitative feedback interview
Other interventionPost-intervention qualitative feedback interview (with a subset of patients and support persons)
Feasibility: Accrual rates [Patients]
Will assess the percentage of eligible approached patients who consent to enroll in the study
Feasibility: Accrual rates [Support persons]
Will assess the percentage of eligible approached support persons who consent to enroll in the study
Feasibility: Rates of intervention completion [Patients]
Will assess the percentage of enrolled patients who complete the intervention
Feasibility: Rates of intervention completion [Support persons]
Will assess the percentage of enrolled support persons who complete the intervention
Change in treatment preference
This will be assessed in patients with an item used previously in our team's NCI-funded cohort studies that asks patients to express a preference for life-extending versus comfort care (two answer choices).
Change in treatment preference
This will be assessed in patients with an item used previously in our team's NCI-funded cohort studies that asks patients to express a preference for life-extending versus comfort care (two answer choices).
Change in healthcare utilization (summary score for total number of healthcare services utilized)
This measure will assess patients' receipt of life-prolonging care (number of emergency room visits, hospital admissions, length of stay in the hospital, rates of ICU admission) and use of palliative or hospice care (length and duration of palliative and/or hospice care). A total score will be created for healthcare utilization.
Change in healthcare utilization (summary score for total number of healthcare services utilized)
This measure will assess patients' receipt of life-prolonging care (number of emergency room visits, hospital admissions, length of stay in the hospital, rates of ICU admission) and use of palliative or hospice care (length and duration of palliative and/or hospice care). A total score will be created for healthcare utilization.
Click on the lead sponsor to view all of their trials.
Fred Hutchinson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
